Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730094 | SCV000857807 | benign | not specified | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000907767 | SCV001052492 | benign | not provided | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440569 | SCV002753170 | benign | Cardiovascular phenotype | 2019-09-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002493320 | SCV002803281 | benign | Lipase deficiency, combined | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000907767 | SCV001919537 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000730094 | SCV001963665 | benign | not specified | no assertion criteria provided | clinical testing |